BIO CapEx to Revenue

Bio-Rad Laboratories, Inc. Class A Common Stock · CapEx to Revenue

BIO logo

BIO CapEx to Revenue

Current (TTM)5.39%
BIO CapEx/Revenue (0.00% → 5.39%)
High-resolution chart · PNG

BIO capex to revenue history

Annual fiscal periods. Dates are reporting period ends; fiscal years can differ from calendar years.

Bio-Rad Laboratories, Inc. Class A Common Stock CapEx to Revenue — Annual fiscal periods
Period endingCapEx to Revenue
6.101%
7.3641%
5.8654%
4.0738%
4.5764%
4.2647%
4.2624%
5.6691%
5.3296%
6.8452%
5.614%
6.2747%
5.0339%
6.9905%
4.983%
4.8017%
4.2797%
5.0335%
4.2894%
4.1593%
3.053%
5.5498%
6.877%
4.7298%
5.2878%
4.3266%
41.8744%
4.7975%
12.8367%
3.6294%
3.1014%
2.7582%
4.4127%
6.1762%
9.9775%
4.6739%
5.6708%
0%
0%
0%
0%
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.